Form 4 for PRVA Privia Health Group, Inc.
Accepted 2021-11-26 00:00:00 ET · period of report 2021-11-23 · accession 0000950103-21-018642 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-26 | 2021-11-23 | PRVA | Morris Matthew Shawn | CEO, Dir | M - OptEx | $2.00 | +339.1K | 460.8K | +279% | +$678.1K |
| D | 2021-11-26 | 2021-11-23 | PRVA | Morris Matthew Shawn | CEO, Dir | S - Sale+OE | $27.70 | -339.1K | 121.7K | -74% | -$9.39M |
| D | 2021-11-26 | 2021-11-23 | PRVA | Morris Matthew Shawn | CEO, Dir | M - OptEx | $0.00 | -339.1K | 5.54M | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value per share | 2021-11-23 | M | A | 339,062 | $2.00 | 460,801 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value per share | 2021-11-23 | S | D | 339,062 | $27.70 | 121,739 | D | — | — | (F2) This amount represents the $29.00 secondary public offering price per share of Common Stock of Privia Health Group, Inc., less the underwriting discount of $1.305 per share. |
| 3 | Derivative | Stock Option (Right to Purchase) | 2021-11-23 | M | D | 339,062 | $0.00 | 5,540,620 | D | $2.00 · 2019-08-28 to 2033-08-27 | 339,062 Common Stock |